Skip to main content
logo
NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0580
-0.0050 (-7.94%)
Oct 8, 2026, 2:09 PM AEST

ASX:NSB Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
23232961126
Market Cap Growth
-56.15%-20.53%400.23%-49.60%-55.56%-46.27%
Enterprise Value
1817242816
Last Close Price
0.060.060.090.040.080.18

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
---17.84--
PS Ratio
56.1457.10-2.622.32-
PB Ratio
1.531.551.721.082.444.68
P/TBV Ratio
4.985.073.991.172.604.97
P/FCF Ratio
---136.31--
P/OCF Ratio
---130.72--

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
44.8541.32-1.111.65-
EV/EBITDA Ratio
---9.93--
EV/EBIT Ratio
---15.76--
EV/FCF Ratio
---57.68--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.010.01----
Net Debt / Equity Ratio
-0.31-0.31-0.43-0.93-1.05-1.31
Net Debt / EBITDA Ratio
1.371.373.79-20.094.410.69
Net Debt / FCF Ratio
1.641.646.46-116.752.131.04
Asset Turnover
0.030.03-0.410.76-
Quick Ratio
14.1614.1649.3558.468.303.31
Current Ratio
14.2714.2749.5658.878.393.34
Return on Equity (ROE)
-29.68%-29.68%-16.65%6.46%-20.93%-103.71%
Return on Assets (ROA)
-18.30%-18.30%-11.21%1.81%-11.24%-58.19%
Return on Capital Employed (ROCE)
-31.70%-31.70%-11.90%2.90%-25.00%-190.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-20.76%-20.41%-6.38%5.61%-9.31%-40.41%
FCF Yield
-12.29%-12.08%-3.89%0.73%-20.08%-26.90%
Buyback Yield / Dilution
-129.96%-129.96%-1.49%-0.72%--